In mouse models of GBM, blocking of CTLA-4, PD-1/PD-L1, and TIGIT has been shown to result in increased survival, frequently associated with depletion of immunosuppressive cells and an influx of effector T cells into the tumor (222, 228–231). The gene discussed is CD274; the disease is neoplasm.